ID

29898

Description

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00446511

Link

https://clinicaltrials.gov/show/NCT00446511

Keywords

Versions (2)
  1. 4/26/18 4/26/18 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 26, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT00446511

English

Eligibility Hypertension NCT00446511

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
successful completion of 12 weeks of double-blind treatment in core protocol cval489k2302.
Description

Therapeutic procedure Double-Blind Method Successful Completed

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0013072
UMLS CUI [1,3]
C1272703
UMLS CUI [1,4]
C0205197
patients participating in study cval489k2302 who may have discontinued prematurely due to uncontrolled hypertension defined as mssbp > 20%, but < 25% above the 95th percentile for age, gender, and height after visit 5, qualifies a patient for entry into this extension study.
Description

Study Subject Participation Status Clinical Trial Discontinued | Uncontrolled hypertension | Sitting systolic blood pressure mean | Age | Gender | Body Height

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C1444662
UMLS CUI [2]
C1868885
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
UMLS CUI [4]
C0001779
UMLS CUI [5]
C0079399
UMLS CUI [6]
C0005890
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
renal artery stenosis.
Description

Renal Artery Stenosis

Data type

boolean

Alias
UMLS CUI [1]
C0035067
current diagnosis of heart failure (nyha class ii-iv).
Description

Heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
second or third degree heart block without a pacemaker.
Description

Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent

Data type

boolean

Alias
UMLS CUI [1]
C0264906
UMLS CUI [2]
C0151517
UMLS CUI [3,1]
C0030163
UMLS CUI [3,2]
C0332197
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
Description

Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC

Data type

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0741212
clinically significant valvular heart disease.
Description

Heart valve disease

Data type

boolean

Alias
UMLS CUI [1]
C0018824
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy and av block controlled with a pacemaker.
Description

ECG abnormality | Exception Left Ventricular Hypertrophy | Atrioventricular Block Controlled by Artificial cardiac pacemaker

Data type

boolean

Alias
UMLS CUI [1]
C1832603
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0149721
UMLS CUI [3,1]
C0004245
UMLS CUI [3,2]
C0332298
UMLS CUI [3,3]
C0030163
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
Description

Solid organ transplant | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status

Data type

boolean

Alias
UMLS CUI [1]
C0730400
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0022671
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023911
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0018823
UMLS CUI [5,1]
C0021079
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C0205360
patients who experienced any adverse events considered serious and drug related in protocol cval489k2302.
Description

Serious Adverse Event | Adverse reaction to drug

Data type

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2]
C0041755
other protocol-defined inclusion/exclusion criteria applied to the study.
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Hypertension NCT00446511

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Therapeutic procedure Double-Blind Method Successful Completed
Item
successful completion of 12 weeks of double-blind treatment in core protocol cval489k2302.
boolean
C0087111 (UMLS CUI [1,1])
C0013072 (UMLS CUI [1,2])
C1272703 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
Study Subject Participation Status Clinical Trial Discontinued | Uncontrolled hypertension | Sitting systolic blood pressure mean | Age | Gender | Body Height
Item
patients participating in study cval489k2302 who may have discontinued prematurely due to uncontrolled hypertension defined as mssbp > 20%, but < 25% above the 95th percentile for age, gender, and height after visit 5, qualifies a patient for entry into this extension study.
boolean
C2348568 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C1868885 (UMLS CUI [2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C0001779 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
C0005890 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Renal Artery Stenosis
Item
renal artery stenosis.
boolean
C0035067 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
current diagnosis of heart failure (nyha class ii-iv).
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent
Item
second or third degree heart block without a pacemaker.
boolean
C0264906 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
C0030163 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC
Item
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
boolean
C0003811 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
Heart valve disease
Item
clinically significant valvular heart disease.
boolean
C0018824 (UMLS CUI [1])
ECG abnormality | Exception Left Ventricular Hypertrophy | Atrioventricular Block Controlled by Artificial cardiac pacemaker
Item
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy and av block controlled with a pacemaker.
boolean
C1832603 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149721 (UMLS CUI [2,2])
C0004245 (UMLS CUI [3,1])
C0332298 (UMLS CUI [3,2])
C0030163 (UMLS CUI [3,3])
Solid organ transplant | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status
Item
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
boolean
C0730400 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0022671 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023911 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0018823 (UMLS CUI [4,2])
C0021079 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C0030705 (UMLS CUI [6,1])
C0205360 (UMLS CUI [6,2])
Serious Adverse Event | Adverse reaction to drug
Item
patients who experienced any adverse events considered serious and drug related in protocol cval489k2302.
boolean
C1519255 (UMLS CUI [1])
C0041755 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria applied to the study.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial